Dosimetry of lesions in radioiodine therapy of metastatic throid cancer: SPECT-TC calibration, verification and preliminary patient results. (September 2016)
- Record Type:
- Journal Article
- Title:
- Dosimetry of lesions in radioiodine therapy of metastatic throid cancer: SPECT-TC calibration, verification and preliminary patient results. (September 2016)
- Main Title:
- Dosimetry of lesions in radioiodine therapy of metastatic throid cancer: SPECT-TC calibration, verification and preliminary patient results
- Authors:
- Richetta, E.
Radici, L.
Cutaia, C.
Valzano, S.
Moro, G. Lo
Pasquino, M.
Pellerito, R.E.
Stasi, M. - Abstract:
- Abstract : Introduction: 131 I is used in treatment of metastatic thyroid cancer. Higher activity seems to improve the outcome compared to multiple lower treatments. Patient-specific dosimetry avoids adverse effects and allows appropriate metastasis irradiation. SPECT-TC is more accurate to estimate activity than planar methods. Purpose: To define quantitative SPECT-TC lesion dosimetry protocol. Materials and methods: Three hollow spheres (11.5, 5.6 and 1.1 ml) and a cylinder (130 ml), filled with liquid 131 I (13 MBq/ml) and placed into a water phantom, were acquired (SPECT-TC SiemensIntevo, 64views, 20s/view, circular-orbit, 128 × 128 and 256 × 256) on successive days (dead time 26 ÷ 0.5%). Images were Iterative (Flash3D) scatter-attenuation corrected. Detectors counts-rates and dead-time were noted. Counts/activity were evaluated on volumes segmented with TC and threshold-method. Partial volume effects, radius dependence (25-33cm) and dead-time were evaluated; calibration's verification and a first patient dosimetry was also reported. Results: Calibration factors (cylinder:25.4, smallest sphere:1.4 kcts/MBq) confirmed partial volume effects. Volume recovery coefficients (130 ml–100%, 11 ml–75%, 5.5ml-58%, 1.1 ml–6%) showed radius dependence (within 4.5 % for cylinder; up to 43% for the smallest sphere). The dead-time versus cts/MBq showed a linear dependence (r 2 = 0.99) that allowed the relative correction. According to literature (MIRD24), calibration's verificationAbstract : Introduction: 131 I is used in treatment of metastatic thyroid cancer. Higher activity seems to improve the outcome compared to multiple lower treatments. Patient-specific dosimetry avoids adverse effects and allows appropriate metastasis irradiation. SPECT-TC is more accurate to estimate activity than planar methods. Purpose: To define quantitative SPECT-TC lesion dosimetry protocol. Materials and methods: Three hollow spheres (11.5, 5.6 and 1.1 ml) and a cylinder (130 ml), filled with liquid 131 I (13 MBq/ml) and placed into a water phantom, were acquired (SPECT-TC SiemensIntevo, 64views, 20s/view, circular-orbit, 128 × 128 and 256 × 256) on successive days (dead time 26 ÷ 0.5%). Images were Iterative (Flash3D) scatter-attenuation corrected. Detectors counts-rates and dead-time were noted. Counts/activity were evaluated on volumes segmented with TC and threshold-method. Partial volume effects, radius dependence (25-33cm) and dead-time were evaluated; calibration's verification and a first patient dosimetry was also reported. Results: Calibration factors (cylinder:25.4, smallest sphere:1.4 kcts/MBq) confirmed partial volume effects. Volume recovery coefficients (130 ml–100%, 11 ml–75%, 5.5ml-58%, 1.1 ml–6%) showed radius dependence (within 4.5 % for cylinder; up to 43% for the smallest sphere). The dead-time versus cts/MBq showed a linear dependence (r 2 = 0.99) that allowed the relative correction. According to literature (MIRD24), calibration's verification showed an accuracy within ± 11 % (except for the smallest volume up to 36 %). Similar results were found for all segmentation methods but the CT-based was the most accurate one. This calibration was applied to a patient lung lesion (56 Gy). Conclusion: SPECT-TC represents the more reliable system for lesion dosimetry, allowing accurate volumes and dead-time correction. … (more)
- Is Part Of:
- Physica medica. Volume 32(2016)Supplement 3
- Journal:
- Physica medica
- Issue:
- Volume 32(2016)Supplement 3
- Issue Display:
- Volume 32, Issue 3 (2016)
- Year:
- 2016
- Volume:
- 32
- Issue:
- 3
- Issue Sort Value:
- 2016-0032-0003-0000
- Page Start:
- 200
- Page End:
- Publication Date:
- 2016-09
- Subjects:
- Medical physics -- Periodicals
Biophysics -- Periodicals
Biophysics -- Periodicals
Imagerie médicale -- Périodiques
Radiothérapie -- Périodiques
Rayons X -- Sécurité -- Mesures -- Périodiques
Physique -- Périodiques
Médecine -- Périodiques
610.153 - Journal URLs:
- http://www.sciencedirect.com/science/journal/11201797 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/11201797 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/11201797 ↗
http://www.elsevier.com/journals ↗
http://www.physicamedica.com ↗ - DOI:
- 10.1016/j.ejmp.2016.07.678 ↗
- Languages:
- English
- ISSNs:
- 1120-1797
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6475.070000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 7456.xml